Quick Answer
LIXTE BIOTECHNOLOGY HOLDINGS, INC. reported Research And Development Expense of $254.9 thousand for the year ending 2025.
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. showed a decrease of -64.9% in Research And Development Expense from 2024 to 2025.
- This data is from LIXTE BIOTECHNOLOGY HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $273.6 thousand | Q2 2012: $217.3 thousand | Q3 2012: $393.7 thousand | Q1 2013: $166.3 thousand | Q2 2013: $248.8 thousand | Q3 2013: $219.9 thousand | Q1 2014: $162.8 thousand | Q2 2014: $335.7 thousand | Q3 2014: $309.1 thousand | Q1 2015: $505.5 thousand | Q2 2015: $287.0 thousand | Q3 2015: $624.4 thousand | Q1 2016: $264.5 thousand | Q2 2016: $316.9 thousand | Q3 2016: $336.0 thousand | Q1 2017: $143.2 thousand | Q2 2017: $14.6 thousand | Q3 2017: $205.7 thousand | Q1 2018: $25.7 thousand | Q2 2018: $41.1 thousand | Q3 2018: $3.5 thousand | Q1 2019: $48.3 thousand | Q2 2019: $80.1 thousand | Q3 2019: $570.6 thousand | Q1 2020: $94.7 thousand | Q2 2020: $117.9 thousand | Q3 2020: $799.4 thousand | Q1 2021: $443.5 thousand | Q2 2021: $262.4 thousand | Q3 2021: $227.2 thousand | Q1 2022: $458.5 thousand | Q2 2022: $164.8 thousand | Q3 2022: $272.4 thousand | Q1 2023: $189.1 thousand | Q2 2023: $427.5 thousand | Q3 2023: $132.5 thousand | Q1 2024: $119.1 thousand | Q2 2024: $210.7 thousand | Q3 2024: $361.6 thousand | Q1 2025: $91.5 thousand | Q2 2025: $60.6 thousand | Q3 2025: $50.7 thousand.
- Over the full 16 years of available data (2010 to 2025), LIXTE BIOTECHNOLOGY HOLDINGS, INC.'s Research And Development Expense has declined by 42.8%.
- Historical annual values: Fiscal year 2025: $254.9 thousand | Fiscal year 2024: $726.2 thousand | Fiscal year 2023: $898.1 thousand | Fiscal year 2022: $1.35 million | Fiscal year 2021: $1.74 million | Fiscal year 2020: $1.22 million | Fiscal year 2019: $820.9 thousand | Fiscal year 2018: $40.7 thousand | Fiscal year 2017: $467.3 thousand | Fiscal year 2016: $870.0 thousand | Fiscal year 2015: $2.09 million | Fiscal year 2014: $1.12 million | Fiscal year 2013: $879.9 thousand | Fiscal year 2012: $1.01 million | Fiscal year 2011: $1.33 million | Fiscal year 2010: $445.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: